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ABSTRAK 
 
Ketagihan alkohol merupakan salah satu faktor yang boleh merangsang pengaktifan 
microglia otak dan membawa kepada inflamasi otak melalui toll-like receptors (TLR) 
yang terdapat di dalam microglia. Ketagihan alkohol menyebabkan defisit motor 
melalui inflamasi otak. Walau bagaimanapun, dasar mekanisme inflamasi otak dalam 
mendorong tingkah laku motor melalui pengaktifan TLR4 masih belum dijelaskan. 
TLR sentiasa didapati berkaitan atau terlibat dalam induksi inflamasi otak dalam 
penyakit degenerasi otak. TLR4 dirangsang oleh TLR4 agonis, Lipopolysaccharide 
(LPS), dan interaksi TLR4-LPS telah didapati menyebabkan perubahan fisiologi dan 
tingkah laku termasuk kecacatan aktiviti motor dalam model tikus. Oleh itu, kajian ini 
bertujuan untuk menyiasat tingkah laku lokomotor, gen reseptor serotonin (HTR1A 
dan HTR2A), reseptor dopamin (reseptor Dopamin D1 dan reseptor Dopamin D2) dan 
pengangkut glutamat (EAAT1 dan EAAT4) dalam striatum dan serebelum berikutan 
rawatan dengan TLR4 agonis. Haiwan telah dibahagikan kepada tiga kumpulan; (1) 
Kawalan (n = 12), (2) rawatan LPS (0.83mg / kg) (n = 12) 6 jam dan (3) rawatan LPS 
(0.83mg / kg) (n = 12) 24 jam. Selepas rawatan, tingkah laku lokomotor dianalisis 
dalam ujian Open field, wooden beam dan hanging wire pada 6 dan 24 jam selepas 
suntikan LPS. Mengikuti ujian tingkah laku, otak haiwan dikeluarkan dan bahagian 
striatum dan serebelum diasingkan untuk kajian gen. Hasil kajian menunjukkan 
bahawa terdapat defisit lokomotor pada 6 jam tetapi tidak dalam 24 jam. Kajian gen 
mencadangkan bahawa terdapat perubahan ketara dalam reseptor serotonin (HTR1A 
dan HTR2A), reseptor dopamin (reseptor Dopamin D1 dan reseptor Dopamin D2) dan 
pengangkut glutamat (EAAT1 dan EAAT4) dalam striatum dan serebelum bersama-
sama dengan defisit motor. Kesimpulannya, TLR4 mungkin menyebabkan defisit 
xiii 
 
motor melalui pengawalaturan pengangkut glutamat EAAT1 dalam striatum dan 
serebelum. 
Kata kunci: Inflamasi otak, Toll-like receptor 4, deficit motor, striatum dan 
serebelum. 
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ABSTRACT 
 
Alcohol addiction is one of the possible factors in stimulating brain microglia 
activation and leading to neuroinflammation through toll-like receptors (TLR) which 
are present in microglia. In fact, alcohol addiction ultimately causes motor deficits 
through neuroinflammation. However, the underlying mechanisms of 
neuroinflammation inducing motor behaviour through activation of TLR4 receptors 
have not yet been elucidated. TLR are always found to be associated or involved in 
the induction of neuroinflammation in neurodegenerative diseases. TLR4 is stimulated 
by TLR4 Agonist, Lipopolysaccharide (LPS), and the TLR4-LPS interaction has been 
found to result in physiological and behavioural changes including retardation of 
motor activity in the mouse model. Therefore, the present study aimed to investigate 
the locomotor behaviour, gene expression of serotonin receptors (HTR1A and 
HTR2A), dopamine receptors (Dopamine D1 receptor and Dopamine D2 receptor) and 
glutamate transporters (EAAT1 and EAAT4) in the striatum and cerebellum following 
treatment with TLR4 agonist. The animals were divided into three groups; (1) Control 
(n=12), (2) LPS treatment (0.83mg/kg) (n=12) 6 h and (3) LPS treatment (0.83mg/kg) 
(n=12) 24 h. After treatment, locomotor behaviour was analysed in open field test, 
wooden beam test and hanging test at 6 and 24 h post-LPS administration. Following 
behaviour test, animal’s brains were harvested and striatum and cerebellum isolated 
for gene expression studies. Results showed that there were locomotor deficits at 6 h 
but not in 24 h. The gene expression studies suggested that there were significant 
changes in serotonin receptors (HTR1A and HTR2A), dopamine receptors (Dopamine 
D1 receptor and Dopamine D2 receptor) and glutamate (EAAT1 and EAAT4) 
transporters in the striatum and cerebellum along with motor deficits. In conclusion, 
xv 
 
TLR4 possibly causes motor deficits through regulation of glutamate transporter 
EAAT1 in striatum and cerebellum.  
Key words: Neuroinflammation, Toll-like receptor 4, motor deficits, striatum and 
cerebellum. 
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          CHAPTER 1 
 
INTRODUCTION 
 
Neurological diseases particularly Alzheimer disease (AD), Parkinson disease 
(PD), strokes and epilepsy are on the rise all around the world. As the second leading 
cause of morbidity and mortality globally, it has become one of the greatest threats to 
public health (Feigin et al., 2017; World Health Organization, 2006). All the 
aforementioned diseases share a common symptom of gradual loss or impairment of 
motor behaviour. Based on the Global Burden of Disease Study 2015, neurological 
diseases were listed and emerged as the top disease to cause 250.692 million disability-
adjusted life-years (DALYs), comprising 10.2% of global DALYs, and 9.399 million 
deaths, comprising 16.8% of global deaths, the second highest in terms of global 
deaths. Therefore, from the statistics, it is evident how critical it is to research on ways 
to alleviate the distress, the physical constraint that is affecting the people (Feigin et 
al., 2017). 
 
It has been noted that the motor loss associated with neurological diseases are 
possibly resulted from neuroinflammation induced by the neuroimmune system (Glass 
et al., 2010). Many studies had been performed involving animal models, proving the 
causal relationship between neuroinflammation and motor deficits.  
Neuroinflammation itself is considered a critical hallmark in the pathogenesis of 
neurological diseases, making it one of the major focus of this study. The immune 
system is one of the major functional component of the body that is responsible for the 
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occurrence of neuroinflammation. One of the major, active components of the 
neuroimmune systems is the toll-like receptors (TLRs).  
 
TLRs are always found to be associated or involved in the induction of 
neuroinflammation in neurodegenerative diseases. TLRs are a family of 
transmembrane pattern recognition receptors (PRR) that sense, recognize and identify 
pronounced structures in microbes, known as pathogen associated molecular patterns 
or PAMPs as part of the signal transduction of the innate immune system. TLRs are 
present in the central nervous system (CNS), specifically and primarily expressed in 
microglia and is also found on neurons and astrocytes, functioning mainly in the 
regulation of pro-inflammatory cytokines production that subsequently contribute to 
neuronal damage (Shmuel-Galia et al., 2017). For example, deficiency of toll-like 
receptor 2 (TLR2) and toll-like receptor 4 (TLR4) in mice exhibit reduced levels of 
pro-inflammatory cytokines resulting in milder clinical disease following traumatic 
brain injury. Subsequently, increased expression of TLR4 are also found in PD, AD 
and amyotrophic lateral sclerosis (ALS) patients as well as in animal models (Molteni 
et al., 2016). 
 
TLR4 particularly has been demonstrated in various studies to have a 
significant causal relationship with motor dysfunction in neurodegenerative 
conditions. Activation of TLR4 through TLR4 agonist, lipopolysaccharide (LPS) 
stimulation initiate a signalling cascade whereby the TLR4-LPS interaction has been 
found to result in physiological and behavioural changes including retardation of 
motor activity in the mouse model (Bison et al., 2009; Cunningham et al., 2009; Tar 
et al., 2012). LPS is a component of gram-negative bacteria known to trigger 
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inflammation, specifically known to activate TLR4. A number of studies reported the 
suppression of neuroinflammation through TLR4 inhibition which consequently 
minimized motor deficit in animal models involving neurodegenerative diseases as 
well as traumatic brain injury (Feng et al., 2017; Feng et al., 2016; Lee et al., 2015; 
Hines et al., 2013; Ahmad et al., 2013). Numerous studies had demonstrated a 
significant relationship between TLR4 and motor impairments in neurodegenerative 
disorders. A recent study demonstrated an increase in motor impairments in a mice 
model as a result of TLR4 activation using monophosphoryl lipid A (Venezia et al., 
2017). The recent study done by Fellner and colleagues (2017) using ALS mouse 
model and TLR4 inhibitor TAK-242 (resatorvid), the inhibitory effect on TLR4 was 
reflected in the reduction of the spinal cord pathology along with the motor 
impairments. The role of TLR4 in the initiation of neuroinflammation is very much 
well-grounded and it is similar in the case of TLR4 causal effect on motor function. 
 
 Although many studies had demonstrated the correlation between TLR4 and 
motor deficits, the functional molecular mechanisms of TLR4 in contributing to motor 
impairments in neurodegenerative disorders however, still clearly has not been 
defined. Therefore, this study attempts to investigate the functional mechanism of 
TLR4 in contributing to motor impairments by activating the TLR4 using TLR4 
agonist, LPS using a mouse model. This study proposed the use of LPS to stimulate 
the activation of TLR4 mainly due to the physiological and behavioural changes 
following the TLR4-LPS interactions. This is further supported by a study done by 
Sharma and colleagues (2016) which demonstrated the suppression of LPS induced 
motor deficits using Apocyanin in rat model. Previous studies also demonstrated that 
LPS induced neuroinflammation which later contributed to physiological and 
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neurobehavioral deficits (Tien et al., 2017). However, the underlying functional 
molecular mechanisms of TLR4 involved in causing motor deficit were not clearly 
mentioned.  
 
Striatum which is a component of the basal ganglia, is involved in facilitating 
voluntary movement while the cerebellum is involved in the maintenance of balance 
and coordination of voluntary movements (Leisman & Melilo, 2013). Both these 
structures work together with the cerebral cortex in mediating movements and various 
neurotransmitters are involved in the circuitries involved in the process. Dopamine, 
serotonin, gamma-aminobutyric acid (GABA) and glutamate, to name a few, interact 
in regulating the excitation and inhibition of motor neurons. Studies had long 
demonstrated the involvement of such neurotransmitters in the proper functioning of 
motor neurons in striatum and cerebellum (Wankhar et al., 2017; Hernandez-Rabaza 
et al., 2016; Karamanolis et al., 2016). In the motor system, serotonin (5-
hydroxytryptamine, 5-HT) is found to either enhance or depress glutamate-mediated 
transmission as well as GABA mediated transmission in structures controlling 
movement (Ciranna, 2006). Additionally, TLR4 activation by LPS is noted to release 
pro-inflammatory cytokines, interleukin 1 beta (IL-1β) from microglia that 
subsequently suppresses GABA receptor activities at the postsynaptic site and reduces 
GABA synthesis at the presynaptic site. Glial glutamate transporter activities are also 
found to be suppressed, showing the association between TLR4 activation and the 
related neurotransmitters and corresponding receptors and transporters in the event of 
neuroinflammation (Yan, Jiang & Weng, 2015). The lack of research on the underlying 
transmission of TLR4 induced motor deficit involving changes in neurotransmitters 
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and corresponding receptors and transporters create gaps that needs to be filled. This 
contributes to our initiative in pursuing this research project. 
 
Loss of motor function disrupts and affects the quality of life, burdening people 
suffering from the associated diseases. Although relationship between 
neuroinflammation and TLR4 had been widely studied and its functional role in the 
pathogenesis of motor deficits among neurological disorders was demonstrated, the 
functional mechanism and pathway involved that led to the deficit however, has yet to 
be clearly defined. Findings constituting the underlying implication and pathway of 
TLR4 on motor functions can be used to provide alternatives in treating the effects of 
neurodegenerative diseases. Therefore, in this project, we investigate the relevant 
neuroinflammation mechanism of LPS-induced TLR4 on motor functions by assessing 
motor behaviours of LPS induced adult male mice and examining associated neuronal 
damage and changes in genes of neurotransmitter’s receptors and transporters located 
in the striatum and cerebellum region that are involved in motor behaviour.   
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CHAPTER 2 
 
 
LITERATURE REVIEW 
 
2.1 Microglia 
 
Microglia are the innate immune cells in the CNS whereby it monitors and 
regulates the brain homeostasis, maintaining it under normal physiological conditions 
by purging pathogens, as well as clearing dead cells through phagocytosis. Most 
notably, the microglia are critically involved in the neuroinflammatory response, 
serving as the initial indication of neuroinflammation when activated. The presence of 
pathogens, tissue damage, abnormal stimulation, neurotoxins, infection, injury or any 
threats to the microenvironment activates microglia and thereafter, the complex 
neuroinflammatory pathway (Shabab, 2016).  
 
Macrophages can be activated into several distinct activation states and the 
microglia functions differently according to the different activation states. The 
classical M1 type activation is the response to micro-organism threats and is associated 
with cytotoxicity and inflammatory responses including the upregulation of pro-
inflammatory cytokines expression. On the other hand, the M2 type activation is 
associated with immunoregulatory functions, tissue repair as well as wound healing 
and regeneration (Subramaniam & Federoff, 2017; Kaminska, 2016; Boche et al., 
2013). In response to an extensive and diverse array of microbial stimuli, the 
differential activation of microglia regulates neuroinflammation by inducing the 
release of pro-inflammatory mediators that favour the permeabilization of the blood 
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brain barrier (BBB), which results in either neurotoxicity or neuroprotection (Chen et 
al., 2016). Such stimuli are recognized by an array of receptors on microglia. Then, the 
event follows the release of signals termed as PAMPs as well as damage associated 
molecules patterns (DAMPs) which are transmitted by the damaged cells. PAMPs and 
DAMPs in turn are recognized and bound by PRRs (Molteni, 2016). One of the highly 
conserved PRRs involved in the local immune response is the TLRs family. 
 
Fig. 2.1 Activation states of microglia (Arcuri et al., 2017) 
 
 
2.2 Neuroinflammation 
 
Motor deficit emerged as a prominent feature or symptom in 
neurodegenerative diseases such as PD, AD, stroke and etc. Motor deficits linked to 
said diseases usually shows in the form of motor slowing (bradykinesia), gait and 
posture disturbances, rigidity and resting tremor (Buchman & Bennett, 2011; Wirths 
& Bayer, 2008). It has been noted that the motor loss associated with 
neurodegenerative diseases are possibly resulted from neuroinflammation induced by 
the neuroimmune system (Glass et al., 2010). In researches involving PD and AD, 
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neuroinflammation has been reported to play the central role in the pathogenesis of 
these diseases. Neuroinflammation is regarded as an important feature of many 
neurodegenerative diseases such as multiple sclerosis (MS), narcolepsy and autism 
(Shabab, 2016). 
 
Neuroinflammation stems from the immune system of the CNS and comprises 
of a complex series of local immune processes constituting CNS cells such as neuron 
and glia, cytokines, PRRs, and peripheral immune cells in response to threats such as 
pathogens, tissue damage, abnormal stimulation, neurotoxins, infection or injury. The 
initiation, progression and termination of neuroinflammation are mediated through the 
activation of glial cells such as microglia, macroglia and astrocytes and is subsequently 
followed by the release of pro-inflammatory cytokines and chemokines as well as 
reactive oxygen and nitrogen species (Saavedra-López et al., 2017). 
Neuroinflammation can assume a neuro-protective role or it can be counterproductive, 
causing damage to the nervous tissues. A persistent acute neuroinflammation can turn 
to a chronic neuroinflammation as it accumulates damage, bringing about neuronal 
degeneration. The effects or outcome of neuroinflammation has been indicated to be 
dependent on the time span of the inflammatory response and the activation state of 
microglia (Stone at al., 2016; Milatovic et al., 2014). Subsequently, one of the 
outcomes of neuroinflammation is the alteration of neurotransmission which 
consequently results in the modification of neurotransmitter receptors, dopamine, 
serotonin, glutamate and GABA, thus, causing a hindrance towards spatial learning, 
cognitive and motor functions (Leite et al., 2017; Ihara et al., 2016).  
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2.3 Toll-like receptor on motor and sickness behaviour 
 
PRRs are employed as sensors in the signal transduction of the innate immune 
system for the initial detection of microbial threats. Activated PRRs effectuate 
downstream signaling pathways which induces the innate immune responses by 
producing pro-inflammatory mediators, resulting in inflammation. One out of the 
several distinct classes of PRRs include the TLRs family. TLRs are always found to 
be associated or involved in the induction of neuroinflammation in neurodegenerative 
diseases. TLRs are known to regulate the production of pro-inflammatory cytokines, 
which may contribute to further neuronal damage (Shmuel-Galia et al., 2017). There 
are a total of 10 members of the TLRs family in human; TLR1–TLR10 and 12 
members in mice; TLR1–TLR9, TLR11–TLR13. TLRs are expressed either on the 
exterior of microglia cells or to intracellular compartments such as the ER, endosome, 
lysosome, or endolysosome. Cell surface TLRs include TLR1, TLR2, TLR4, TLR5, 
TLR6, and TLR10, whereas intracellular TLRs include TLR3, TLR7, TLR8, TLR9, 
TLR11, TLR12, and TLR13 (Kawasaki & Kawai, 2014). 
 
TLR4 particularly has been demonstrated in various studies to have a 
significant causal relationship with motor dysfunction in neurodegenerative 
conditions. TLR4 and other cell surface TLRs mainly detect and identify microbial 
membrane components, for example lipids, lipoproteins, and proteins (Kawasaki & 
Kawai, 2014). TLR4 activates upon stimulation of the gram-negative LPS which are 
known to trigger inflammation. The TLR4-LPS interaction has been found to result in 
physiological and behavioural changes including retardation of motor activity, loss of 
interest or pleasure, impaired cognitive function, social withdrawal, as well as reduced 
food and water intake (Lim et al., 2012; Bison et al., 2009). Additionally, pro-
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inflammatory cytokines produced by TLR4-activated microglia has shown to induce 
sickness behaviour characterized by reduced food intake and locomotor activity 
(Felger & Miller, 2012). A study by Venezia and colleagues (2017), activation of 
TLR4 using monophosphoryl lipid A resulted in increased motor impairments. To 
further confirm TLR4 role in motor behaviour, the effect of completely blocking LPS-
induced activation of TLR4 was investigated. TLR4 blockage with Tat-TLR4 
interfering peptides injection was reported to suppress the event of sickness behaviour 
and exhibited absence of motoric and motivational effects of LPS-induced sickness 
(Hines et al., 2013). Additionally, morphological changes in microglia and cytokine 
production that are typically induced by LPS were also blocked. Inhibition of TLR4 
signaling prevents changes in behaviour and motivation caused by inflammatory 
stimulation, further suggesting the role and contribution of TLR4 in motor deficit.  
 
Another study by Fellner and colleagues (2017) demonstrated reduced motor 
impairments as well as spinal cord pathology in ALS mouse model by using the 
inhibitor TAK-242 to impede TLR4 activation. This was also supported by Lee et al. 
(2015) which demonstrated increased motor function in relation to a decrease in 
microglial activation in the absence of TLR4 in ALS mouse model. Furthermore, 
suppression of TLR4 was also observed to reduce motor deficits conditions in 
neurodegenerative disorders and traumatic brain injury animal model (Akbar et al., 
2013). Feng et al., in 2016 and 2017, administered resatorvid, the TLR4 inhibitor 
TAK-242, in a rat subjected to controlled cortical impact injury. The result showed a 
neuroprotective effect through the inhibition of the TLR4-mediated pathway whereby 
the expression of TLR4 and its downstream signaling molecules, including MyD88, 
TRIF, NF-κB, TNF-α, and IL-1β, was found to be significantly downregulated. 
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However, a study by Zhu and colleagues (2016) revealed a morphological-based 
analysis that linked TLR4 deficiency with thinning of the molecular layer of the 
cerebellum. The loss of TLR4 reduced the number of Purkinje cells (PCs) which are 
the sole output neurons of the cerebellar cortex, thus impairing motor function as PCs 
are responsible in regulating the function of cerebellum which plays an essential role 
in balance and motor coordination (Zhu et al., 2016).  
 
2.4 Toll-like Receptor 4 (TLR4) Neuroinflammatory Signaling Pathway 
 
Activation of TLRs initiate two signal transduction pathways namely the 
MyD88-dependent pathway and the MyD88-independent pathway. TLRs except 
TLR3 initiate intracellular signaling through ligand-induced dimerization of 
intracellular Toll-IL-1 receptor (TIR) domain (Kaminska, 2016) (Fig. 2.2). TIR 
domains of TLR4 recruit TIR domain-containing adaptor proteins MyD88 and MAL 
of the MyD88-dependent pathway or TRIF and TRAM of the MyD88-independent 
pathway. The MyD88-dependent pathway activates IRAKs (IRAK1, IRAK2, and 
IRAK4) and TRAF6 that in turn activates TAK1. Subsequently, this leads to the 
activation of MAPKs (p38, JNK, and ERK1/2) and IKK pathways, resulting in NF-κB 
activation which then induce the production of pro-inflammatory cytokines. The 
MyD88-independent pathway on the other hand activates TRIF and TRAM adaptor 
proteins which then recruits TBK1/IKK𝜀 through the activation of TRAF3. This then 
follows the activation the transcription factor IRF3 in the nucleus leading to the 
production of type I interferons (IFNs) (Molteni, 2016; Kawasaki, 2014) (Fig. 2.3). 
Once LPS binds to TLR4 on the microglia surface, the signal transduction pathway is 
activated which in the end leads to NF-κB activation. Activated NF-κB functions to 
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control DNA transcription, mediating the production of pro-inflammatory cytokines, 
chemokines and inducible enzymes, namely, inducible nitric oxide synthase (iNOS) 
and COX-2 which are released from the microglia whereby all result in 
neuroinflammation (Rietdijk et al., 2016; Shabab et al., 2016). 
 
Fig. 2.2 Structure of Toll-like receptor 4 (Czerkies & Kwiatkowska, 2014) 
 
 
Fig. 2.3 TLR4 signaling pathway (Molteni et a., 2016) 
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Previous studies had demonstrated that microglia in the brain region comprise 
an expression of TLR4 (Crews & Vetreno, 2016) and that the TLR4 activation 
activates microglia which in turn produces more pro-inflammatory factors such as 
TNFα, IL-1β and IL6 (Sulakhiya et al., 2016; Fan et al., 2011; Bison et al., 2009), 
resulting in a self-propelling and vicious cycle of neuroinflammation and 
neurodegeneration of dopamine neurons (Qin et al., 2007). The production of pro-
inflammatory cytokines is shown to be associated with reduced muscle mass and 
strength as well as affecting brain areas involved in motor coordination and fatigue 
(Krzyszton et al., 2008). To counter such reaction, IL-10, an anti-inflammatory 
cytokine, is produced by macrophages to suppress excess production of inflammatory 
cytokines and excessive inflammation (Iyer et al., 2012). Both NF-κB and IL-10 plays 
a functional role in the production and regulation of such pro-inflammatory cytokines 
respectively. Pro-inflammatory cytokines produced as a result of TLR4 activation and 
NF-κB triggering could affect the expression and regulation of neurotransmitters and 
receptors in the striatum and cerebellum in a way that possibly results in impaired 
motor functions. 
  
2.5 Striatum and Cerebellum 
The striatum is one of the main component of the basal ganglia which is 
involved in processes related to voluntary motor control. The striatum can be further 
divided into the dorsal striatum which consists of the caudate nucleus and putamen, 
and the ventral striatum which comprise of the nucleus accumbens and the olfactory 
tubercle. The striatum acts as the central glutamatergic and dopaminergic input 
receiving station and subsequently transmits these inputs to the rest of the basal 
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ganglia. Within the striatum, the received inputs are projected onto two distinct classes 
of medium spiny neurons (MSNs) specified as the direct (striatonigral) and indirect 
pathway (striatopallidal) MSNs (Hutton et al., 2017; Kravitz & Kreitzer, 2012).  
 
These two pathways differ whereby the direct pathway MSNs directly 
transmits inputs from the cortex and thalamus to the internal globus pallidus (GPi) and 
substantia nigra pars reticulata (SNr) while the indirect pathway MSNs receives input 
from the cortex and thalamus and indirectly transmits the outputs to SNr through the 
external globus pallidus (GPe) and subthalamic nucleus (STN) (Fig. 2.4). Moreover, 
the direct pathway MSNs express high levels of D1 dopamine while the indirect 
pathway MSNs has a high expression of D2 dopamine. Additionally, projections from 
the direct pathway MSNs is reported to mediate motor output, whereas projections 
from the indirect pathway MSNs impede motor output. The opposing activity of the 
two pathways is what regulates motor control (Do et al., 2013).  
 
 
 
Fig. 2.4 Direct and indirect pathways of motor circuit in the striatum (Lewis 
et al., 2003) 
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Dysfunction of the connectivity or projections of the striatum is recognized as 
a notable cellular pathology in a number of motor and neurodegenerative diseases such 
as PD and Huntington’s disease (HD). PD is associated with a progressive decline in 
motor control. The causal circumstance of such decline is due to a dysfunction of the 
motor circuits within the striatum which is resulted from dopamine denervation in the 
dorsal striatum ascribable to the death of dopaminergic neurons in the SNr (Simioni et 
al., 2016; Kravitz, 2012). The role of striatum in the pathogenesis of PD has been 
reiterated and supported by various past studies and articles (Singh et al., 2016; 
Hanganu et al., 2015; Maurice at al., 2015). 
 
As like PD, HD is a neurodegenerative disease clinically characterized motor 
impairment. Equally, degeneration of striatal neurons is attributed as one of the 
underlying contributing cause of this disease. Guo and colleagues (2012) in their study 
reported a significant causal relationship between size and volume reduction as well 
as neuronal loss in both STN and putamen of post-mortem brains of HD patients with 
increase clinical motor impairment. Such losses and atrophy in both structure disrupts 
motor circuits within the striatum, thus leading to motor impairments in HD patients. 
This is supported by a recent study by Chan and colleagues (2015) on transgenic HD 
monkey model using magnetic resonance imaging (MRI) and reverse transcription and 
quantitative PCR (qPCR). Similarly, results showed degeneration distinguished by 
significant neuronal loss in both caudate nucleus and putamen suggests a progressive 
regional degeneration and significant volume reduction in the striatum. Consequently, 
these losses affect the fronto-striatal pathways and causes erratic striatal outputs, 
impeding the motor functions in HD monkeys.  
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The cerebellum, also known as the “little brain”, is the major folded structure 
of the hindbrain. It consists of two cerebellar hemispheres whereby the cerebellar 
cortex comprises of three layers, which are the internal granular layer with granule 
cells, the middle PC layer consisting of single row of PCs, and the external molecular 
layer which is made up of primary glial cells. Axons of granule cells and the dendrites 
of PCs stretch out all the way into the molecular layer. Inputs from the cerebral cortex 
is transmitted to the cerebellum by mossy fibres which then excites the granule cells 
of the granular layer. The granule cells then specialized into parallel fibres which 
synapse onto PCs dendrites, transmitting excitatory signals. At the same time, PCs also 
receive regulatory input through its axons from climbing fibres that stems from the 
inferior olive. PCs then sends an inhibitory signal to the deep cerebellar nucleus 
neurons that proceed toward the motor cortex. Concurrently, both mossy fibres and 
climbing fibres excites the deep cerebellar nucleus neurons. The output from deep 
cerebellar nucleus neurons thus depends on the overall inhibitory and excitatory 
stimulation (Salman & Tsai, 2016; Kandel et al., 2013) (Fig. 2.5).  
 
 
Fig. 2.5 Layers of the cerebellum and the transmission pathway 
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The cerebellum is critically involved in modulating various networks including 
voluntary motor control and cognition. Studies have showed a causal role of 
cerebellum dysfunction in motor impairment in a number of diseases such as PD, and 
neurological movement disorders such as dystonia and multiple systemic atrophy 
(MSA). Mormina and colleagues (2017) discussed changes in cerebellum in 
neurodegenerative diseases through the use of MRI. All the aforementioned diseases 
are characterized with distinguished motor impairments and cerebellum dysfunction 
as their pathological hallmark. Loss in cerebellar volume was reported in PD patients 
with tremor due to cerebellar atrophy. Additionally, cerebellar hyperactivity was 
shown to be higher in PD patients. Similarly, atrophy of the middle cerebellar 
peduncles and volume loss of the middle and inferior cerebellar peduncles were also 
observed in MSA patients. Cerebellar atrophy and increased cerebellum activation 
together with the presence of cerebellar lesions and morphological cerebellar anomaly 
were observed in dystonia patients with hand stiffness. Dystonia is associated with 
continuous, unusual muscle contractions.  
 
Another MRI study on the involvement of cerebellum in the pathogenesis of 
ALS were conducted by Tan et al. (2014). ALS is a neurodegenerative disorder 
involving the motor neuron system in which it affects muscle contractions and 
progressively impact normal movement abilities. Motor impairments in ALS patients 
were linked with atrophy in the inferior cerebellum specifically the inferior lobules 
and vermis. Both the basal ganglia and the cerebellum interact with the cerebral cortex 
whereby the neuronal activity between the three structures are involved with 
parameters of movement (Leisman & Melilo, 2013). In addition, past literatures 
reported that the primary brain regions most affected by inflammatory response 
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include the basal ganglia, particularly the ventral striatum (Miller et al., 2013). Both 
striatum and cerebellum are selected as the areas of interest due to their involvement 
in motor control.  
 
 
Fig. 2.6 Location of the striatum and cerebellum in an adult mouse brain 
(Adapted from Konno et al., 2014) 
 
 
2.6 Neuroinflammation on Neurotransmitter’s receptors and transporters 
 
 Neurotransmitters are a diverse group of chemical compounds that are 
involved in the transmission of information in chemical synapses from the presynaptic 
site of one neuron to postsynaptic site of the adjacent neuron. Neurotransmitters from 
the presynaptic neuron diffuses into the synaptic cleft where they bind accordingly to 
their specific receptors to activate the respective signalling cascades. The 
neurotransmitters then either undergoes the reuptake process by presynaptic 
transporter proteins and astrocytes or be degraded by specific enzymes that are present 
in the synaptic cleft. The resulting signalling cascade can elicit either an excitatory or 
inhibitory signal. Thus, neurotransmitters can be of either excitatory or inhibitory in 
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nature and are grouped accordingly based on structure and function (Leite et al., 2017). 
Some of the neurotransmitters group are as follows; acetylcholine, amino acids 
(glycine, glutamate and GABA (gamma amino-butyric acid)), amino acid derived 
amines (epinephrine, norepinephrine, dopamine and serotonin), peptides (substance P 
and endorphins), purines (ATP) and gases (nitric oxide). Excitatory neurotransmitters 
include serotonin, acetylcholine, epinephrine and norepinephrine whereas inhibitory 
neurotransmitters include glycine and GABA. Studies had long demonstrated the 
involvement of various neurotransmitters in the proper functioning of motor neurons 
in the striatum and cerebellum (Wankhar et al., 2017; Hernandez-Rabaza et al., 2016; 
Karamanolis et al., 2016). These studies involved the investigation of the functional 
relationship between neurotransmitters such as serotonin, GABA, dopamine and 
glutamate with motor functioning.  
 
Dopamine, unlike other neurotransmitters, can act as both inhibitory and 
excitatory neurotransmitter depending upon its location in the brain and which receptor 
it binds to. Dopamine receptors (DRs), Dopamine Receptor D1 (DRD1) mediates 
excitatory signal while Dopamine Receptor D2 (DRD2) mediates inhibitory signals. 
DRD1 is highly distributed in the striatum, nucleus accumbens, olfactory tubercle, 
cerebral cortex and amygdala. Additionally, DRD2 is also highly communicated in the 
striatum, olfactory tubercle, nucleus accumbens as well as in the SNc and ventral 
tegmental area (VTA). The striatum acts as one of the main target region for dopamine 
involving the regulation of motor functions. Dopamine is critically involved in 
numerous brain circuits in the nervous systems associated with mediating motor 
control, feeding behavior, cognitive functions, emotion, motivation and reward 
(Nakamura et al., 2014).  
 
20 
 
 
Dopamine, is generally known to be involved in the modulation of motor 
functions and this has been stated and reiterated in numerous studies and articles. 
Neurotransmission and projections of dopamine from the substantia nigra (SN) to the 
striatum, and to the cerebellum from the VTA has been noted to influence the fine 
tuning of movements (Triarhou, 2013; Wu & Hallet, 2013). Nuclei in both SNc and 
the VTA is reported to make up the major dopaminergic tracts (Nakamura et al., 2014). 
The corticostriatal circuit expresses high levels of both DRD1 and DRD2, 
demonstrating the involvement of such receptors in controlling movement, thus 
justifying the selection of DRD1 and DRD2 in this study. Additionally, varied 
connection strength between striatum–cortical, striatum–cerebellar and cortico-
cerebellar motor influenced by imbalanced neurotransmission of dopamine were 
observed in Parkinson’s patients with akinesia (Wu & Hallet, 2013). Subsequently, the 
production of cytokine during neuroinflammation is found to be involved in the 
alterations in dopamine neurotransmission whereby cytokines ultimately lead to 
decreased dopamine synthesis, thus decreasing dopamine function which could lead 
to neurodegeneration. 
 
Serotonin acts upon excitatory transmission and operates as a mediator in 
inflammatory processes. 5-HT neurons is widely dispersed in the raphe nuclei of the 
brain stem such as the pons and medulla oblongata and additionally other brain regions 
for example, the striatum, hippocampus, amygdala, cerebral cortex, thalamus, 
hypothalamus and spinal cord (Ohno et al., 2015). Besides governing the regulation of 
critical physiological processes such as motor activity, sleep, body temperature and 
pain, 5-HT is also significant in mediating endocrine and autonomic systems as well 
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as emotional behaviour and cognitive function (Strac et al., 2016; Ohno et al., 2015). 
5-HT has been reported to enhance and/or depress glutamate-mediated transmission 
as well as GABA-mediated transmission in structures controlling movement (Ciranna, 
2006). 5-HT receptors, sorted into 7 families consisting of 5-HT1, 5-HT2, 5-HT3, 5-
HT4, 5-HT6 and 5-HT7, mediate the serotonergic signal transduction. These 7 families 
are further broken down into 14 subtypes which are 5-HT1A, 1B, 1D, 1E, 1F, 5-HT2A, 
2B, 2C, 5-HT3, 5-HT4, 5-HT5A, 5B, 5-HT6 and 5-HT7. Found at both pre and post-
synaptic membrane, the 5-HT receptors with the exception of 5-HT3 receptors which 
are ligand-gated ion channels, are G protein-coupled receptors (Ohno et al., 2015; 
2013).  
Various 5-HT receptors mediating 5-HT neurotransmission were reported in 
the regulation of extrapyramidal motor functions which are implicated in the 
pathophysiology of various neurological disorders. This is supported by the findings 
of the ameliorating effect of 5-HT1A receptors activation on antipsychotic-induced 
extrapyramidal side effects (EPS) and motor disabilities in animal models of PD in a 
study by Ohno et al. (2011). Specifically, 5-HT1A and 5-HT2A/2C receptors are 
amongst the multiple receptors that is of great significance in the modulation of motor 
disabilities in animal models of PD (Ohno et al., 2015). Past study of such findings 
include an experiment that demonstrated the weakening of L-dopa–induced dyskinesia 
in 6-hydroxydopamine-lesioned rats through in administration of mixed 5-HT1A/1B 
receptor agonist, eltoprazine (Bezard et al., 2013). Another study showed a decrement 
in tacrine-induced tremulous jaw movements in rats which is considered a primary 
motor symptom of tremor, through the administration of 5-HT2A receptor inverse 
agonist and antagonist, ACP-103 (Vanover et al., 2008). Additionally, both 5-HT1A 
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receptor agonist and 5-HT2A receptor inverse agonist and antagonist were shown to 
reduced l-dopa-induced dyskinesia in MPTP-treated macaques. 
 
Glutamate is the most prevalent excitatory neurotransmitter in the CNS, having 
an extensive functional contribution in both the CNS and peripheral nervous system 
(PNS) processes as it is involved in various metabolic pathways. Present on 
glutamatergic neurons, glutamate execute glutamatergic signal transduction by 
binding to and hence, activating both ionotropic and metabotropic glutamate receptors 
located on postsynaptic neurons. Regulation of glutamate is critical as unsuppressed 
glutamate release will result in glutamate dysregulation which poses excitotoxicity 
within the CNS. Such occurrence leads to neuronal damage and even neuronal death. 
Glutamate dysregulation has been well characterized in certain psychiatric, 
neurodevelopmental, and neurodegenerative disorders. The excitatory amino acid 
transporters (EAATs) holds the responsibility in preventing glutamate dysregulation 
by governing the release and reuptake of glutamate. Furthermore, glutamate 
transporters also contribute to learning, memory, and motor behaviour regulation. 
There are a total of five EAAT subtypes which are EAAT1 or GLAST 
(glutamate/aspartate transporter), EAAT2, EAAT3 or EAAC1, EAAT4 and EAAT5 
(Zhang et al., 2016).  
 
Neurological disorders such as stroke, epilepsy, ALS, AD and PD exhibits 
alterations in the function or expression of EAATs in their pathogenesis (Benarroch, 
2010). Zhang and colleagues (2016) in their study showed that PD animal models 
exhibit a decreased expression and function of EAATs. EAATs especially EAAT1 is 
important in the maintenance of extracellular glutamate concentrations below 
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glutamate excitotoxic levels where if exceeded results in glutamate neurotoxicity and 
subsequent dopamine neuronal death, movement disorder, and cognitive impairment 
(Chen et al., 2016; Sominsky et al., 2015). Concentration of extracellular glutamate 
increases in the early stages of neuroinflammation due to microglia activation. A study 
by Tsai et al. (2012) demonstrated that fluctuation in neuronal glutamate transporter 
EAAT4 expression levels can alter the extrasynaptic glutamate signaling. 
Furthermore, both direct and indirect pathway of the corticostriatal circuit receive 
glutamatergic inputs whereby Do et al. (2013) suggested that alteration of 
glutamatergic transmission in the dorsal striatum through a form of NMDARs 
blockade may perhaps contribute to hyperactivity of motor function. 
 
While the above studies provide valuable information regarding the potential 
associative mechanism between TLR4, neuroinflammation signaling and motor 
behaviour, there are still gaps in between such as the involvement and potential 
changes in functional neurotransmitter receptors and transporters that needs to be 
investigated in order to know the complete mechanism of TLR4 activation in affecting 
motor behaviour. The known underlying pathway can provide alternative therapeutic 
treatment for existing neurological and motor neuron diseases. Therefore, in this study 
the major focus point was placed on the implication of TLR4 towards the motor 
behaviour and associated neurotransmitter receptors and transporters using mouse 
model.   
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2.7 Rationale 
 
Gradual loss or impairment of motor behavior in neurological and motor 
neuron diseases disrupts and lowers the quality of life of affected people. 
Neuroinflammation has been reported to play the prominent role in the pathogenesis 
of these diseases with various researches reporting the involvement of TLR family, 
specifically TLR4 in resulting physiological and behavioral changes involving 
retardation of motor activity in the mouse model. However, the overall pathway and 
mechanism of how TLR4 is involved in motor behavior has not been known yet. The 
known underlying pathway can provide alternative treatment for existing neurological 
and motor neuron diseases. Therefore, in this project, we focused on the implication 
of TLR4 on motor behavior and associated genes and transporter in a mouse model.  
 
2.8 Hypothesis 
 
Toll-like receptor 4 may regulate motor and sickness behavior through dopamine, 
serotonin receptors and glutamate transporters in striatum and cerebellum of mice. 
 
 
 
 
 
 
 
